ג'נואט 50/500 מ"ג טבליות

País: Israel

Língua: hebraico

Origem: Ministry of Health

Ingredientes ativos:

METFORMIN HYDROCHLORIDE 500 MG; SITAGLIPTIN AS MONOHYDRATE PHOSPHATE 50 MG

Disponível em:

MERCK SHARP & DOHME ISRAEL LTD

Código ATC:

A10BA02

Forma farmacêutica:

TABLETS

Via de administração:

PER OS

Fabricado por:

MERCK SHARP & DOHME CORP., USA

Grupo terapêutico:

METFORMIN

Indicações terapêuticas:

Januet is indicated as an adjunct to diet and exercise to improve glycemic control in adult patients with type 2 diabetes mellitus. Important limitations of use:Januet should not be used in patients with type 1 diabetes or for the treatment of diabetic ketoacidosis, as it would not be effective in these settings.Januet has not been studied in patients with a history of pancreatitis. It is unknown whether patients with a history of pancreatitis are at increased risk for the development of pancreatitis while using Januet.

Data de autorização:

2008-12-01